Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.04 USD
Change Today +0.002 / 5.71%
Volume 3.3M
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

propanc health group corp (PPCH) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/17/15 - $0.13
52 Week Low
01/2/15 - $0.0010
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

propanc health group corp (PPCH) Related Businessweek News

No Related Businessweek News Found

propanc health group corp (PPCH) Details

Propanc Health Group Corporation, a development stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic and colorectal cancer. The company’s lead product includes PRP, a patented formulation consisting of two pro-enzymes, such as trypsinogen and chymotrypsinogen, as well as the enzyme amylase designed to synergistically enhance anti-cancer effects. It is also developing a combination of anti-cancer agents working in combination with pro-enzymes, which enhance PRP’s anti-cancer effects. The company was formerly known as Propanc PTY LTD. Propanc Health Group Corporation was founded in 2007 and is based in Camberwell, Australia.

propanc health group corp (PPCH) Top Compensated Officers

Chief Executive officer, Chief Financial offi...
Total Annual Compensation: $137.7K
Acting Chief Medical Officer and Member of Sc...
Total Annual Compensation: $7.9K
Compensation as of Fiscal Year 2014.

propanc health group corp (PPCH) Key Developments

Propanc Health Group Corporation Announces Corporate Address Change

On May 1, 2015, Propanc Health Group Corporation moved its principal executive office to: Level 2, 555 Riversdale Road, Cambwerwell, VIC, 3124 Australia.

Propanc Health Group Corporation Presents at SeeThruEquity 4th Annual MicroCap Investor Conference, May-28-2015 04:00 PM

Propanc Health Group Corporation Presents at SeeThruEquity 4th Annual MicroCap Investor Conference, May-28-2015 04:00 PM. Venue: Convene Grand Central, 101 Park Ave, New York, NY 10178, United States.

Propanc Health Group Corporation announced delayed 10-Q filing

On 11/14/2014, Propanc Health Group Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PPCH:US $0.04 USD +0.002

PPCH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PPCH.
View Industry Companies

Industry Analysis


Industry Average

Valuation PPCH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROPANC HEALTH GROUP CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at